James Shoemaker
Family Medicine · Ormond Beach, FLNPI 1518018530
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 43 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Astellas Pharma US Inc at 25.5% of the total. Reporting peaked in 2019 at $265 and has fallen 56.2% since, to $116 in 2021.
Across 43 payments — averaging $14.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$164
- Amgen$114
- GSK$54
- Amarin Pharma, Inc.$47
- AstraZeneca$45
- Boehringer Ingelheim$41
- plus $179 from 8 others
Across 119 payments — averaging $7629.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biohaven Pharmaceuticals, Inc.$323K
- AbbVie$224K
- Pfizer$172K
- Teva Pharmaceuticals USA, Inc.$52K
- Novo Nordisk AS$31K
- AstraZeneca$31K
- plus $75K from 5 others
What the payments were for
- Food & beverage$64099%
- Education$51%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 10 | $164 |
| Amgen(2 entities) | 8 | $114 |
| GSK | 3 | $54 |
| Amarin Pharma, Inc. | 3 | $47 |
| AstraZeneca | 4 | $45 |
| Boehringer Ingelheim | 3 | $41 |
| AbbVie(2 entities) | 2 | $37 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $35 |
| Sanofi-aventis U.S. LLC | 2 | $33 |
| Vivus LLC | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Pfizer | 2 | $16 |
| Eisai Inc. | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $11 |
How this compares
$644 in reported general payments places this provider in the 55th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Ormond Beach
- John ChewningOrmond Beach$31K
- Noah LeeOakland Park$1.2M
- Angela RosselotBelle Isle$977K
- Richard LappOrlando$702K
- Hal BrownVero Beach$477K
- Lisa EvansBoca Raton$473K
- Giovana Rene CrooksBoca Raton$407K
- Edward BraunSt Petersburg$364K
- Samuel GreenleePensacola$235K
- Kevin FitzgeraldStuart$198K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.